Community-generated resource library-Neisseria gonorrhea and Chlamydia trachomatis Screening at Intrauterine Device Insertion and Pelvic Inflammatory Disease

Neisseria gonorrhea and Chlamydia trachomatis Screening at Intrauterine Device Insertion and Pelvic Inflammatory Disease

Back to course

Pdf Summary

The study conducted by Dr. Carolyn B. Sufrin and colleagues aimed to evaluate the relationship between screening strategies for Neisseria gonorrhea and Chlamydia trachomatis and the risk of developing pelvic inflammatory disease (PID) after the insertion of intrauterine devices (IUDs). This retrospective cohort study at Kaiser Permanente Northern California included 57,728 IUD insertions from 2005 to 2009 and compared PID incidence among women screened for infections with those unscreened within the year before IUD insertion.<br /><br />Findings revealed that nearly half (47%) of the women were not screened for the infections within a year before IUD insertion, and the overall risk of developing PID was low (0.54%). Screening on the same day as IUD insertion was found to have an equivalent risk of PID compared to pre-screening. These results persisted when adjusted for variables like age and race.<br /><br />The study provides evidence that same-day screening for infections during IUD insertion is safe and supports the elimination of barriers like the need for multiple visits for screening, which may deter some women from choosing this effective contraception method. Additionally, the study suggests that routine screening is not necessary for all women unless they present with specific risk factors, aligning with the American College of Obstetricians and Gynecologists guidelines.<br /><br />This research could potentially influence clinical protocols, suggesting that healthcare providers might consider adopting this more flexible screening approach, particularly in regions with low infection prevalence, thereby improving access to IUDs as a long-term contraceptive method. Overall, the findings highlight the importance of tailored healthcare strategies based on individual risk factors rather than blanket screening requirements, facilitating easier access to reliable contraception.

Keywords

Neisseria gonorrhea

Chlamydia trachomatis

pelvic inflammatory disease

intrauterine devices

IUD insertion

screening strategies

retrospective cohort study

same-day screening

contraception access

healthcare protocols